Search results
Results from the WOW.Com Content Network
Dennis Joseph Slamon (born August 6, 1948), [1] [2] is an American oncologist and chief of the division of Hematology-Oncology at UCLA.He is best known for his work identifying the HER2/neu oncogene that is amplified in 25–33% of breast cancer patients and the resulting treatment trastuzumab.
The Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA, also known as the UCLA Broad Stem Cell Research Center, is a biomedical research center at the University of California, Los Angeles that focuses on stem cell research. The center's more than 250 faculty members represent the UCLA professional schools as ...
Drug Design, Development and Therapy is a peer-reviewed medical journal covering research on drug design and development through to clinical applications. The journal was established in 2007 and is published by Dove Medical Press .
For premium support please call: 800-290-4726 more ways to reach us
The primary sponsor of the center is the Jonsson Cancer Center Foundation (JCCF), [2] a 501(c)(3) entity (established in 1945). [6]The center employs over 500 physicians and scientists, who engage in clinical activities (i.e., cancer treatment), education, research (basic and clinical), and cancer prevention.
Robin Kelley (PhD UCLA 1987)- Distinguished Professor and Gary B. Nash Endowed Chair in U.S. History at UCLA. Mark Kleiman – professor of public policy , expert on crime and drug policy Peter Kollock (1959–2009) – associate professor of sociology, specialist in collaboration and online participation in virtual communities
Harbor-UCLA is one of only six accredited medical training institutions out of 880 across the nation facing a blanket probation. Of the six, Harbor-UCLA is by far the largest and best-known.
However, the modalities can be combined; antibody-drug conjugates combine biologic and cytotoxic mechanisms into one targeted therapy. Another form of targeted therapy involves the use of nanoengineered enzymes to bind to a tumor cell such that the body's natural cell degradation process can digest the cell, effectively eliminating it from the ...